Larodopa - Drug Details
๐Ÿ“Š Estimates Larodopa Dialyzability By Different_Modalities

Larodopa

Complete Drug Information

Drug Name
Larodopa
Trade Names
Larodopa, Dopar, Inbrija
Pregnancy Category
AU: B3
Bioavailability
30%
Routes of Administration
Oral, inhalation, enteral (tube), subcutaneous (as foslevodopa)
Metabolism
Aromatic-.mw-parser-output span.smallcaps{font-variant:small-caps}.mw-parser-output span.smallcaps-smaller{font-size:85%}l-amino-acid decarboxylase
Elimination
0.75โ€“1.5 hours
Excretion
Renal 70โ€“80%
Formula
C9H11NO4
Molar Mass
197.19
Drug Class
Dopamine precursor; Dopamine receptor agonist
Volume of Distribution
C9H11NO4

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.